Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUNAR
NCT02973789Phase 3Completed
- Sponsor
- NovoCure
- Start
- Dec 2016
- Primary completion
- Sep 2024
- Countries
- 18
01
Overview
Phase 3, randomised, open-label trial in non-small cell lung cancer (NSCLC) (2 arms), sponsored by NovoCure. Primary endpoint: Overall Survival. Started Dec 2016; status: completed.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02973789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02973789.